Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00825383
Other study ID # DF498
Secondary ID
Status Completed
Phase N/A
First received January 19, 2009
Last updated June 19, 2013
Start date January 1993
Est. completion date December 1995

Study information

Verified date June 2013
Source University of Texas Southwestern Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Effect of Dietary Fiber on glucose, lipid, and mineral metabolism in patients with non insulin dependent diabetes mellitus.


Description:

Two diets will be compared,a low fiber diet and a high fiber diet. These two diets will differ only in the content of total dietray fiber derived from natural food products. The diets will be identical in terms of total energy, percentage of total energy as proteins, fat and carbohydrates.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date December 1995
Est. primary completion date December 1995
Accepts healthy volunteers No
Gender Both
Age group 35 Years to 80 Years
Eligibility Inclusion Criteria:

- NIDDM

- age 35 to 80 years

- stable oral hypoglycemic treatment for at least one month

- fasting triglycerides < 500 mg/dl

Exclusion Criteria:

- insulin dependent NIDDM

- insulin dependent diabetes

- hepatic disease

- significant hepatic dysfunction

- signifiacnt renal dysfunction

- presence of significant hematological, neurological, cardiovascular or gastrointestinal disorder, unless stable for past 6 months,

- serious intercurrent illness or anticipated major surgery

- female pregnant or likely to become pregnant

- chronic drug abuse, alcoholism or psychaitric disorder within the past 2 years

- treated with beta adrenergic blockers

- on lipid lowering drugs

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
High Fiber and Moderate Fiber Diets
Dietary

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Texas Southwestern Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary glucose and lipid metabolism Baseline and during the last 5 days of each 6 week dietary phase No
Secondary calcium isotope absorption in the gastrointestinal tract, stool mineral content, 24 h urinary mineral concentration, and serum chemistry including mineral concentration. Baseline and during the last 5 days of each 6 week dietary phase No
See also
  Status Clinical Trial Phase
Completed NCT00231387 - Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus Phase 3
Completed NCT00318656 - 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes Phase 4
Terminated NCT01582282 - Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects Phase 4
Not yet recruiting NCT06401733 - Intensive Aerobic and Resistance Exercise Program (IAREP) N/A
Completed NCT02722499 - Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) N/A
Completed NCT01472328 - Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes N/A
Completed NCT00269061 - Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin Phase 1
Completed NCT00291356 - GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients Phase 2
Completed NCT00359112 - AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes Phase 3
Completed NCT00156897 - Efficacy and Safety of ATL-962 in Obese Diabetics Phase 2